Bayview Legacy, LLC 4

What Happened
Bayview Legacy, LLC (a reported 10% owner of Arteris, Inc.) sold a total of 125,976 shares on July 6, 2026 in open-market/private transactions, generating aggregate proceeds of approximately $4,509,185. The sales were reported in three lots: 29,490 shares at a weighted avg of $37.07 ($1,093,209), 27,908 shares at a weighted avg of $36.24 ($1,011,288), and 68,578 shares at a weighted avg of $35.06 (~$2,404,688). These were dispositions (sales), which are typically routine; the transactions were executed pursuant to a pre-established 10b5-1 trading plan.

Key Details

• Transaction date: 2026-07-06; Form 4 filed 2026-07-08 (appears timely).
• Reported sale lots and prices:
  • 29,490 shares @ weighted avg $37.07 (actual prices ranged $36.66–$37.58).
  • 27,908 shares @ weighted avg $36.24 (actual prices ranged $35.66–$36.655).
  • 68,578 shares @ weighted avg $35.06 (actual prices ranged $34.64–$35.63).
• Total shares sold: 125,976; total proceeds ≈ $4,509,185.
• Shares owned after transaction: not included in the provided summary of this filing.
• Notable footnotes: sales were made under a 10b5-1 plan adopted Dec 12, 2025 (F1); K. Charles Janac, manager of Bayview Legacy, separately filed a Form 4 reporting the same transactions (F2); Janac is deemed to have voting/dispositive power over these shares (F4).

Context
These sales were made by a 10% owner via a 10b5-1 trading plan, meaning they were pre-scheduled and not necessarily indicative of new, private views on the company. Bayview Legacy is an institutional holder controlled by K. Charles Janac (who filed separately as the manager). Sales by large shareholders can affect float and supply but do not by themselves confirm management sentiment.